Specific T cell responses to tumor associated antigens from melanoma patients undergoing immune checkpoint blockade therapy

Explore related products in the following collection:

Poster Abstracts - C717

ePosters - C717

Related Products

Thumbnail for Promotion of immunogenicity using epigenetic modulation and immune checkpoint inhibition in mouse models of breast cancer

Promotion of immunogenicity using epigenetic modulation and immune checkpoint inhibition in mouse models of breast cancer

Thumbnail for β -Alethine, An Immunostimulatory Drug That Synergizes With Anti-PD1 Therapy

β -Alethine, An Immunostimulatory Drug That Synergizes With Anti-PD1 Therapy

Thumbnail for Blimp-1+ regulatory T cells are associated with longer disease-free survival in colorectal cancer

Blimp-1+ regulatory T cells are associated with longer disease-free survival in colorectal cancer

Thumbnail for Beyond Immune Checkpoint: First-in-Class antibody targeting soluble NKG2D ligand sMIC for cancer immunotherapy

Beyond Immune Checkpoint: First-in-Class antibody targeting soluble NKG2D ligand sMIC for cancer immunotherapy

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.